Contact Us

Yes. ZnT1 rescue experiments require attention to plasma membrane targeting: • Construct design: use a codon-modified SLC30A1 sequence with a small C-terminal tag (FLAG, HA). The 6 transmembrane ZnT family architecture must be preserved. • Transport-deficient rescue: histidine-rich loop mutations or transmembrane zinc-binding site mutations enable structure-function studies. • Surface localization validation: confirm plasma membrane localization by cell surface staining before zinc efflux assays. • Functional readout: rescue should restore cellular zinc efflux and zinc tolerance under challenge conditions. HEK293 transduces efficiently with lentivirus and supports stable rescue line generation.

The choice depends on whether you are studying ferroportin's role as the principal cellular iron exporter or modeling hemochromatosis type 4 and ferroportin disease. The Knockout line is the standard tool for asking whether ferroportin is required for iron efflux — ferroportin is the only known mammalian cellular iron export transporter, expressed on enterocytes, macrophages, and hepatocytes. Overexpression is useful for studying ferroportin in heterologous expression systems and for testing hepcidin-mediated regulation. For iron homeostasis research, the EDITGENE Ferroportin Knockout in HEK293 is the standard mechanistic platform — HEK293 has been extensively used for ferroportin biochemistry and structural studies. Rescue with wild-type, hepcidin-resistant (C326S), or ferroportin disease-associated mutant SLC40A1 enables comprehensive disease modeling. SLC40A1 mutations cause autosomal dominant hemochromatosis type 4/ferroportin disease — disease variant rescue is a standard genotype-function approach.

Yes. Ferroportin rescue experiments are well-established in iron biology research: • Construct design: use a codon-modified SLC40A1 sequence with a small C-terminal tag (FLAG, HA). Ferroportin has 12 transmembrane domains — N-terminal tags must not disrupt topology. • Hepcidin-resistant rescue: the C326S mutation prevents hepcidin binding and creates a hepcidin-insensitive ferroportin — invaluable for studying iron export independent of hepcidin regulation. • Disease mutation rescue: A77D (classical 'loss-of-function'), N144H, and other hemochromatosis type 4-associated mutations enable disease genotype-function studies. • Functional readout: rescue should restore ⁵⁹Fe efflux from preloaded cells and hepcidin-induced ferroportin internalization (where wild-type protein is used). HEK293 transduces efficiently with lentivirus and is the standard heterologous expression background for ferroportin biochemistry and disease modeling.

The choice depends on whether you are studying SLC37A4 (glucose-6-phosphate translocase/G6PT)'s role in hepatic and renal glucose-6-phosphate transport or modeling glycogen storage disease type Ib. The Knockout line is the standard tool for asking whether G6PT is required for transporting glucose-6-phosphate across the ER membrane — G6PT partners with glucose-6-phosphatase to enable gluconeogenesis and glycogenolysis. Overexpression is useful for testing rescue with disease-associated mutations or for biochemical reconstitution studies. For glucose metabolism research, the EDITGENE SLC37A4 Knockout in HEK293 is a mechanistic platform, though physiological gluconeogenesis requires hepatic models. SLC37A4 mutations cause glycogen storage disease type Ib (GSD1b), characterized by hypoglycemia, neutropenia, and inflammatory bowel disease — disease variant rescue enables genotype-function studies. Empagliflozin has been shown to treat GSD1b neutropenia, making this knockout relevant for SGLT2 inhibitor mechanism studies in this context.

Yes. G6PT rescue experiments are well-established for GSD1b research: • Construct design: use a codon-modified SLC37A4 sequence with a small cytoplasmic C-terminal tag (FLAG, HA). G6PT is an ER membrane protein with 10 transmembrane domains — preserve ER targeting determinants. • ER localization validation: confirm ER localization by calnexin co-staining before functional assays. • GSD1b mutation rescue: patient-derived SLC37A4 mutations (e.g., R28H, W118R, common deletions) enable comprehensive disease genotype-function studies. • Functional readout: rescue should restore glucose-6-phosphate translocation activity measured in microsomal preparations. HEK293 transduces efficiently with lentivirus and supports stable rescue line generation.

The choice depends on whether you are studying SLC30A3 (ZnT3)'s role in vesicular zinc loading or its functions in synaptic zinc and Alzheimer's disease contexts. The Knockout line is the standard tool for asking whether ZnT3 is required for transporting zinc into synaptic vesicles — ZnT3 is principally expressed in zincergic neurons in the hippocampus and cortex. Overexpression is useful for studying vesicular zinc loading in heterologous systems. Important consideration: ZnT3 is primarily neuronal — HEK293 is not the physiological context for ZnT3 function. The EDITGENE Knockout in HEK293 is most useful for in vitro biochemistry, structure-function studies, and as a negative control background for heterologous ZnT3 reconstitution. For physiological synaptic zinc research, neuronal models are more appropriate. Rescue with wild-type or transport-deficient ZnT3 enables mechanistic dissection.

Yes, with heterologous expression considerations: • Construct design: use a codon-modified SLC30A3 sequence with a small C-terminal tag (FLAG, HA). The 6 transmembrane ZnT family architecture must be preserved. • Heterologous expression context: HEK293 does not normally express ZnT3 at functional levels — rescue is a controlled heterologous expression study, useful for biochemical and structure-function research. • Transport-deficient rescue: histidine-rich loop or transmembrane zinc-binding residue mutations enable structure-function studies. • Functional readout: rescue should restore vesicular zinc loading in heterologous expression context, assessed by organelle-targeted zinc sensors. HEK293 transduces efficiently with lentivirus and supports stable rescue line generation.

The choice depends on whether you are studying SLC5A6 (SMVT)'s role as a sodium-dependent multivitamin transporter or its essential functions in biotin, pantothenate, and lipoate uptake. The Knockout line is appropriate for asking whether SMVT is required for these vitamin transport activities — SMVT is the principal transporter for these substrates in most tissues. Overexpression is useful for transport kinetics studies and for examining substrate specificity. For SMVT research, the EDITGENE Knockout in HEK293 is a standard mechanistic platform for vitamin transport biology — HEK293 has well-characterized transfection-based experimental capabilities. This product complements the parallel SLC5A6 Knockout in HCT 116 (also available). SMVT mutations cause biotin-thiamine-responsive basal ganglia disease in some clinical contexts. Rescue with wild-type or transport-deficient SMVT enables structure-function studies, and is critical as a specificity control for SMVT-mediated drug-vitamin conjugate delivery research.

Yes. SMVT rescue experiments are well-established for multivitamin transport research: • Construct design: use a codon-modified SLC5A6 sequence with a small C-terminal tag (FLAG, HA). SMVT has 13 transmembrane domains — N-terminal tags must not disrupt membrane insertion. • Transport-deficient rescue: sodium-binding or substrate-binding pocket mutations enable structure-function studies. • Vitamin-conjugate studies: rescue enables direct comparison of SMVT-mediated uptake of native vitamins versus biotinylated drug conjugates. • Functional readout: rescue should restore ³H-biotin, ³H-pantothenate, and ³H-lipoate uptake activities. HEK293 transduces efficiently with lentivirus and is the standard heterologous expression background for SMVT biochemistry.

The choice depends on whether you are studying SPPL3's role as a non-canonical signal peptide peptidase or its emerging functions in glycoprotein homeostasis and ectodomain shedding. The Knockout line is appropriate for asking whether SPPL3 is required for proteolytic processing of glycosyltransferases (B4GALT1, ST6GAL1, others) — a function that distinguishes SPPL3 from related SPPL proteases. Overexpression is useful for testing whether elevated SPPL3 drives enhanced ectodomain shedding of these substrates. For SPPL family research, the EDITGENE SPPL3 Knockout in HEK293 is the standard mechanistic platform — HEK293 has been extensively used for SPPL substrate characterization and structural studies. Rescue with wild-type or catalytically-dead SPPL3 is the standard specificity control. The role of SPPL3 in modifying cellular glycoprofile makes the knockout particularly valuable for glycobiology research.

Yes. SPPL3 rescue experiments require attention to membrane topology and protease activity: • Construct design: use a codon-modified SPPL3 sequence with a cytoplasmic C-terminal tag (FLAG, HA). SPPL3 is a multi-pass membrane intramembrane aspartyl protease — the catalytic YD and GxGD motifs in the membrane domain must be preserved. • Catalytically-dead rescue: mutations in the catalytic aspartates (D205A or D271A in conserved YD or GxGD motifs) abolish protease activity and serve as the standard specificity control. • Substrate-specific rescue: rescue should restore proteolytic processing of glycosyltransferase substrates (assessed by Western blot or glycoprofile analysis). • Localization validation: confirm Golgi localization of exogenous SPPL3 by immunofluorescence co-staining with GM130 before functional assays. HEK293 transduces efficiently with lentivirus and supports SPPL3 expression at levels enabling biochemical characterization.

The choice depends on whether you are studying SLC43A2 (LAT4)'s role in basolateral large neutral amino acid efflux or its specific contributions distinct from LAT1/LAT2. The Knockout line is the standard tool for asking whether LAT4 is required for sodium-independent transport of branched-chain amino acids (leucine, isoleucine, valine), methionine, and phenylalanine — particularly relevant in epithelial transepithelial amino acid handling. Overexpression is useful for transport kinetics studies — notably, LAT4 functions independently of 4F2hc unlike LAT1 and LAT2. For LAT family research, the EDITGENE SLC43A2 Knockout in HEK293 is a mechanistic platform distinct from heterodimeric LAT1/LAT2 — LAT4 is a uniporter that does not require 4F2hc partnership, simplifying transport activity reconstitution. Rescue with wild-type or transport-deficient LAT4 enables structure-function studies and substrate specificity characterization independent of heterodimer assembly considerations.

Yes. LAT4 rescue experiments are well-established for amino acid transport research: • Construct design: use a codon-modified SLC43A2 sequence with a small C-terminal tag (FLAG, HA). The 12 transmembrane architecture must be preserved. • 4F2hc independence: unlike LAT1 and LAT2, LAT4 does not require 4F2hc for surface expression — rescue can be performed without co-expression considerations. • Transport-deficient rescue: substrate-binding pocket mutations enable structure-function studies. • Functional readout: rescue should restore branched-chain amino acid uptake measured by radiolabel or LC-MS. HEK293 transduces efficiently with lentivirus and supports stable rescue line generation.

The choice depends on whether you are studying SLC39A1 (ZIP1)'s role in zinc uptake or its specific contributions distinct from other plasma membrane ZIP family members. The Knockout line is appropriate for asking whether ZIP1 is required for cellular zinc influx — ZIP1 is broadly expressed and contributes to zinc uptake in many cell types. Overexpression is useful for testing transport activity and for studying ZIP1's reported tumor-suppressive role in prostate cancer. For ZIP1 research, the EDITGENE Knockout in HEK293 is a standard mechanistic platform. ZIP family redundancy is important — ZIP2, ZIP3, ZIP4 expression should be assessed in parallel given functional overlap. Rescue with wild-type or transport-deficient ZIP1 enables structure-function studies.

Yes. ZIP1 rescue experiments require attention to plasma membrane targeting: • Construct design: use a codon-modified SLC39A1 sequence with a small C-terminal tag (FLAG, HA). ZIP1 has 8 transmembrane domains in the canonical ZIP family architecture. • Transport-deficient rescue: histidine-rich loop mutations enable mechanistic studies. • Surface localization validation: confirm plasma membrane localization before functional zinc uptake assays. • Functional readout: rescue should restore zinc uptake activity measured by zinc-sensitive fluorescent probes. HEK293 transduces efficiently with lentivirus and supports stable rescue line generation.